Alzheimers & Dementia

Papers
(The H4-Index of Alzheimers & Dementia is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The Design of SPRINT MIND and SPRINT MIND 20202810
Survey on knowledge of Uruguayan neurologist about the FINGER intervention2119
Approach for developing interpretative cut‐points during implementation of a plasma p‐tau217 assay in the clinical laboratory2042
Exploring Alzheimer’s disease progression through the lens of genetics and sleep disturbances772
The power of cognitive rehabilitation in Alzheimer’s disease ‐A Systematic review and meta analysis516
Examining the impact of hormone therapy and Alzheimer’s disease risk factors on depressive symptoms in the Harvard Aging Brain Study463
Relationship between perivascular spaces and white matter hyperintensities in Alzheimer’s disease272
Neural flexibility as a promising biomarker for Alzheimer’s Disease266
The Types and Consistency of Participant‐Specified Proxies During SPRINT230
Influence of tau on non‐traditional memory scores in early‐onset Alzheimer’s disease215
Putative Cellular Identity of Dystrophic Neurites in FTLD‐TDP Type C205
Racial disparities in Alzheimer’s Disease (AD): Correlating a novel neuropsychological screening test to established AD fluid and imaging biomarkers in African Americans and Caucasians202
Investigating the Association Between P2Y12 Receptor, SV2A, and Tau Expression in Postmortem AD and Control Brains Using In Vitro Autoradiography199
Neuroprotective Potential of Limonene in LPS induced Parkinson’s Disease in Rats187
Glial and synaptic biomarkers as early indicators of mild cognitive decline177
Use of a blood‐based amyloid test for screening in INVOKE‐2: a phase 2 randomized, double‐blind, placebo‐controlled study evaluating AL002 in early Alzheimer’s disease161
The effect of virtual reality and physical exercise training on cognitive function in older adults with mild cognitive impairment147
Longitudinal neuropsychological evaluation allows diagnosis of MCI with less severe memory change142
Physical Activity, Social Support, and the Health of Dementia Caregivers: A Scoping Review140
Frontotemporal Dementia & the Criminal Legal System: Care Partner Stories139
Childhood trauma and cognition status in an elderly sample with a mental disorder134
SENSE‐Cog Residential Care: A Pilot Cluster Randomized Trial on Hearing and Vision Support for Residents with Dementia in Long‐term Care121
Digits Across Languages: The Role of Lexical and Numerical Characteristics in Digit Span Performance Across Fourteen Languages117
Who Uses Memory Strategies? Exploring the Influence of Cognitive Reserve on Use of Memory Strategies by Older Adults Referred for Neuropsychological Assessment114
Reducing Gerontophobia and Improving Cognition: A Study on the Efficacy of Mindfulness‐Based Cognitive Therapy in Older Adults in India114
Ciclosonide reduces lipid droplet burden in APOE4 astrocytes112
“CLOVER” Model of Service and Training Development for the Well‐being of People with Dementia in Residential Care Homes of Hong Kong107
The Dementia Literacy Assessment (DeLA): A Novel Measure of Alzheimer's Disease and Related Disorders Health Literacy in Diverse Populations104
An interrupted time‐series design experiment of research registry recruitment interventions103
Pterostilbene Ameliorates Hyperhomocysteinemia‐Induced Cognitive Impairment: Involvement of Mitochondrial Dysfunction, Synaptic Plasticity, and Adult Neurogenesis101
Herbal Therapeutics in Alzheimer's Disease: Investigating Behavioral and Biochemical Changes in Animal Model97
“ I know you didn’t want to stay ”: Emergency Department Conversations about Disposition for People Living with Dementia97
Dementia registry in Guinea: clinical and etiological aspects at the Neurological Department of the Conakry teaching Hospital97
Simultaneous reduction of amyloid beta and phosphorylated tau for Alzheimer’s Disease with Chemically Optimized Stringed Modifiable Oligonucleotides (COSMOs)96
The Utility of the WMS‐IV LM Subtest as an Inclusionary Measure in Early AD Trials94
Impact of icosapent ethyl on CSF NULISA vascular, metabolic, and AD biomarkers in cognitively unimpaired Veterans at risk for dementia93
Natural Language Processing differentiates between Italian individuals with Nonfluent/Agrammatic from Logopenic variants of PPA92
Anti‐NMDA Receptor Encephalitis in a Young Adult with Neuropsychiatric and Cognitive Symptoms‐ A Case Study92
The glymphatic system's role in linking cardiometabolic health to cerebral small vessel disease and frailty in Chilean healthy older adults91
False Negative Twenty‐Nine Montreal Cognitive Assessment Score in Moderately ADL‐Impaired UDS Patients: A Case Series Study of 23 Patients91
Neuropsychiatric symptom subtypes associated with Alzheimer's disease and related dementia neuropathologic changes in the National Alzheimer's Coordinating Center neuropathology cohort90
Cross‐ validation of Free‐Cog with routinely used cognitive and functional tools in Canadian Memory Clinics88
Neuropsychiatric Symptoms in Comorbid Alzheimer's Disease Neuropathologic Change and Frontotemporal Lobar Degeneration86
Association of MBI‐C scores with clinical outomes in patients with MCI during a 3‐year follow‐up84
Implementation of AD BBMs: Approach in Memory Clinics in the Netherlands84
Effect of Orexin receptor antagonists for patients with Lewy bodies: Lemborexant do not make worse cognitive function and REM sleep Behavior Disorder in DLB83
Genetic Intersections of ADHD and Alzheimer's Disease: A Systematic Review83
Achieving Dissemination and Implementation Success in Dementia Care: A Consideration of Methodological Strategies82
The Impact of Testing Environments on Remote Cognitive Assessments in Alzheimer's Disease82
Trip‐Based Measures of Naturalistic Driving: Exploring connections to older adult drivers with respect to amyloid‐positive and amyloid‐negative81
Predicting brain health in older adults through automated language measures80
Low‐Dose Interleukin‐2 in Patients with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial80
Women are less likely to be eligible for AD trials than men.79
Sensory Healthcare for People with Dementia in Diverse Care Settings79
Distinct trajectories of subjective cognitive decline before diagnosis of neurocognitive disorders: Longitudinal modelling over 18 years78
Rare Dementia Support Canada: Localizing and mobilizing knowledge to build inclusive supports for families affected by atypical dementias78
Cerebellar degeneration and its integrative role in brain networks for social cognition in early‐stage bvFTD77
Nutritional status and eating disturbances among patients with neurocognitive disorder77
EMA perspective on Diagnosis of Alzheimer's76
Evaluating the effect of ethnicity and amyloid on gait speed in the Healthy Aging Brain Study‐Health Disparities Study76
The Moderating Effect of Perceived Susceptibility and Decision Conflict on the Relationship Between Comorbidities and Quality of Life Among Caregivers of People with Dementia76
Pulse pressure is associated with Alzheimer's disease pathology and cognitive decline74
Domestic Environment of Multisensory Stimulation based on Snoezelen principles pilot study74
Evaluating the impact of delayed auditory feedback in primary progressive apraxia of speech: acoustic, perceptual, and patient reported outcomes73
What is the prevalence of impaired cognitive domains in surgical patients? A systematic review and meta‐analysis73
Dementia Dastan: Understanding the Experiences of South Asian Canadians Living with Dementia and their Care Partners73
The Psychological Impact of Receiving a Biomarker Informed ADRD Diagnosis in a Real‐World Sample: the PARADE Study71
Divergent Functional Capacity in Alzheimer's Disease and Frontotemporal Dementia: Insights from the Peruvian Adaptation of the Amsterdam Instrumental Activities of Daily Living Questionnaire71
Statistical innovations in the API ADAD Colombia trial: a randomized, double‐blind, placebo‐controlled, parallel‐group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy69
Exploring Memory Trajectories in Aging: A Longitudinal Study of Superagers and Memory Maintenance69
Exploring Emotional Well‐Being in Exceptional Aging: Data from the SuperAging Research Initiative69
0.074291944503784